Winn-Dixie Offering FluMist Nasal Spray
JACKSONVILLE, Fla. - Select Winn-Dixie, Thriftway and SaveRite pharmacies are now offering the FluMist nasal spray, Jacksonville, Fla.-based Winn-Dixie announced last week.
The vaccinations, which will be administered by a licensed pharmacist, will be available during the stores' regular pharmacy hours. The cost is $59 per vaccination.
"FluMist can be an important preventative measure against the flu," said Winn-Dixie's VP of pharmacy Fred Ottolino. "With flu shots in very limited supply, the nasal spray offers a great alternative that we're pleased to offer our customers."
Winn-Dixie noted that customers are advised to consult with their family doctor before receiving any vaccination.
According to Wyeth Vaccines, FluMist, Influenza Virus Vaccine Live, Intranasal, is indicated for active immunization for the prevention of disease caused by influenza A and B viruses in healthy children and adolescents, 5 to 17 years of age, and healthy adults, 18 to 49 years of age. FluMist is not indicated for immunization of individuals less than 5 years of age, or 50 years of age and older.
FluMist is delivered into the nose, where the flu virus can enter the body. It is different from the flu shot because it contains weakened live influenza viruses instead of killed viruses. Both vaccines contain the three strains of flu virus that the U.S. Food and Drug Administration has selected as the most likely to cause influenza in the coming flu season.
The vaccinations, which will be administered by a licensed pharmacist, will be available during the stores' regular pharmacy hours. The cost is $59 per vaccination.
"FluMist can be an important preventative measure against the flu," said Winn-Dixie's VP of pharmacy Fred Ottolino. "With flu shots in very limited supply, the nasal spray offers a great alternative that we're pleased to offer our customers."
Winn-Dixie noted that customers are advised to consult with their family doctor before receiving any vaccination.
According to Wyeth Vaccines, FluMist, Influenza Virus Vaccine Live, Intranasal, is indicated for active immunization for the prevention of disease caused by influenza A and B viruses in healthy children and adolescents, 5 to 17 years of age, and healthy adults, 18 to 49 years of age. FluMist is not indicated for immunization of individuals less than 5 years of age, or 50 years of age and older.
FluMist is delivered into the nose, where the flu virus can enter the body. It is different from the flu shot because it contains weakened live influenza viruses instead of killed viruses. Both vaccines contain the three strains of flu virus that the U.S. Food and Drug Administration has selected as the most likely to cause influenza in the coming flu season.